Clinical Trial Update: A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease [Phase 4]

View source ↗

Summary

This is a clinical trial update for a Phase 4 study of CREXONT (carbidopa and levodopa) Extended-Release Capsules in Parkinson disease. The study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CREXONT (carbidopa and levodopa)

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Parkinson Disease | Phase 4 | Status: RECRUITING